FDA label
What is Fiasp used for?
Fiasp contains insulin aspart. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “FIASP is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Fiasp?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Fiasp, injection, solution
Indications and Usage, quoted from the label by Novo Nordisk (BLA208751). Cross-references to other label sections are left out.
FIASP is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
Source: DailyMed label, set id 834e7efc-393f-4c55-9125-628562a8a5cf, version 18, effective June 21, 2023. NDC 0169-3201, one of 4 listings for this product.
Questions
What is Fiasp used for?
The FDA label says: “FIASP is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.”
What drug class is Fiasp?
FDA lists insulin aspart in the Insulin Analog established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.